More surprisingly, the lost ability of migration and invasiveness in vitro and tumorigenicity in vivo in the Hsp90α knockout cancer cells could be fully rescued by extracellular supplementation or injection to circulation with human recombinant Hsp90α, but not Hsp90β, protein. This evidence concerns the gene HSP90AB1 and cancer.